Comet Biorefining
Comet Biorefining is an award-winning food technology company based in London, Ontario and Schaumburg, Illinois. The company makes unique, healthy and sustainable products using its patented upcycling technology. Its Arrabina(TM) Arabinoxylan Plant Fiber Extract has superior tolerability and functionality within the prebiotic market.
Sector
Industrial Biotech
Strategy
Status
Live
Website
comet-bio.com
Related News
Comet Bio Announces $22M Round of Equity Financing
Comet Bio Wins “Start-Up of the Year” NutraIngredients Award for 2020
Comet Bio Announces Positive Clinical Trial Results for its Prebiotic Arrabina™
Comet Bio Completes Equity Financing and Opens U.S. Headquarters in Chicagoland Area
Comet Therapeutics Raises $28.5 Million Series A Financing to Support Development of Treatments Built Around Its Novel CoEnzyme A Platform
SofinnovaCapital
The Sofinnova Capital Strategy is our flagship fund, investing as founding or lead investor in early-stage biopharma and medtech start-ups developing groundbreaking therapeutic technologies.
SofinnovaMD Start
The Sofinnova MD Start Strategy is our in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy invests in growth-stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy invests in early-stage sustainable companies across the agriculture, chemicals, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy makes early-stage investments in leading Italian science for the benefit of patients around the world.
SofinnovaDigital Medicine
Our Digital Medicine Strategy backs early-stage techbio and healthtech start-ups at the intersection of biology, data, and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is our biotech accelerator, partnering with leading research organizations to create and build European biotech start-ups.